211 related articles for article (PubMed ID: 9348576)
21. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
22. Combined radiotherapy and chemotherapy with carboplatin and UFT for head and neck squamous cell carcinoma.
Taguchi T; Ikeda Y; Mikami Y; Kawai S; Arai Y; Mochimatsu I; Tsukuda M
Anticancer Res; 2003; 23(1B):713-7. PubMed ID: 12680172
[TBL] [Abstract][Full Text] [Related]
23. [A prospective randomized trial of adjuvant chemotherapy with UFT for head and neck carcinoma. Head and Neck UFT Study Group].
Tsukuda M; Ogasawara H; Kaneko S; Komiyama S; Horiuchi M; Inuyama Y; Uemura T; Uchida M; Kamata S; Okuda M
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1169-77. PubMed ID: 8031158
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic usefulness of postoperative adjuvant chemotherapy with Tegafur-Uracil (UFT) in patients with breast cancer: focus on the results of clinical studies in Japan.
Nakayama T; Noguchi S
Oncologist; 2010; 15(1):26-36. PubMed ID: 20080863
[TBL] [Abstract][Full Text] [Related]
25. Pharmacotherapy of head and neck squamous cell carcinoma.
Pan Q; Gorin MA; Teknos TN
Expert Opin Pharmacother; 2009 Oct; 10(14):2291-302. PubMed ID: 19663637
[TBL] [Abstract][Full Text] [Related]
26. Effects of the anticancer drug cocktail "UFT" on metastatic potentials of squamous cell carcinoma (O-1N) in a hamster model.
Naito Y; Kimura S; Yoshizawa M; Ohtake K; Nakajima T; Saku T
Oral Oncol; 1998 Sep; 34(5):326-31. PubMed ID: 9861336
[TBL] [Abstract][Full Text] [Related]
27. Biweekly paclitaxel, cisplatin, tegafur, and leucovorin as neoadjuvant chemotherapy for unresectable squamous cell carcinoma of the head and neck.
Wang HM; Liao CT; Chang TC; Chen JS; Liaw CC; Chen IH; Tsang NM
Cancer; 2004 Oct; 101(8):1818-23. PubMed ID: 15386306
[TBL] [Abstract][Full Text] [Related]
28. [Determination of 5-FU tissue concentrations after oral UFT administration in tumors of the head and neck].
Somekawa Y; Asano K; Taira A; Imai R
Gan To Kagaku Ryoho; 1996 Jan; 23(1):75-9. PubMed ID: 8546473
[TBL] [Abstract][Full Text] [Related]
29. [Combination therapy with S-1 and CDDP for head and neck cancer].
Fujii M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():150-4. PubMed ID: 16897992
[TBL] [Abstract][Full Text] [Related]
30. [A resected case of squamous cell carcinoma of the breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases].
Hiramatsu K; Kato K; Hirata A; Matsuba H; Hara T; Ito T; Miyata T; Akagawa T; Kutsuna Y; Machiki Y; Fujioka S
Gan To Kagaku Ryoho; 2007 Mar; 34(3):443-6. PubMed ID: 17353640
[TBL] [Abstract][Full Text] [Related]
31. Current chemotherapies for recurrent/metastatic head and neck cancer.
Molin Y; Fayette J
Anticancer Drugs; 2011 Aug; 22(7):621-5. PubMed ID: 21131821
[TBL] [Abstract][Full Text] [Related]
32. [Neo-adjuvant chemotherapy with UFT and adriamycin in head and neck cancer].
Toda K; Kishimoto M; Imura S; Ogasawara H; Hyo N; Kumoi T
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2280-5. PubMed ID: 3111382
[TBL] [Abstract][Full Text] [Related]
33. Docetaxel in squamous cell cancer of the head and neck.
Posner MR
Anticancer Drugs; 2001 Feb; 12 Suppl 1():S21-4. PubMed ID: 11340900
[TBL] [Abstract][Full Text] [Related]
34. Neoadjuvant chemotherapy prior to surgery in head and neck cancer.
Paterson C; Robertson AG; Grose D; Correa PD; Rizwanullah M
Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):79-80. PubMed ID: 22070911
[No Abstract] [Full Text] [Related]
35. The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck.
Posner MR; Colevas AD; Tishler RB
Semin Oncol; 2000 Aug; 27(4 Suppl 8):13-24. PubMed ID: 10952434
[TBL] [Abstract][Full Text] [Related]
36. Rationale for phase I study of UFT plus leucovorin and oral JM-216.
DeMario MD; Ratain MJ
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):26-9. PubMed ID: 9348563
[TBL] [Abstract][Full Text] [Related]
37. [Level of 5-FU in tumor tissues of the patients with head and neck malignant tumors after oral administration of UFT].
Kusama M; Utsunomiya Y; Ono T; Nagura H; Enomoto S
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1796-802. PubMed ID: 6411004
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant chemotherapy with oral tegaful and uracil for maxillary sinus carcinoma.
Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M; Kanzaki J; Inuyama Y
Oncology; 1998; 55(2):109-15. PubMed ID: 9499184
[TBL] [Abstract][Full Text] [Related]
39. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
[TBL] [Abstract][Full Text] [Related]
40. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
Panasci L; Gravenor D; Black M; Frenkiel S; Margolese R
Cancer Treat Rep; 1985 Sep; 69(9):1015-7. PubMed ID: 2411401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
